COGT
Price
$36.09
Change
-$0.75 (-2.04%)
Updated
Feb 5, 02:37 PM (EDT)
Capitalization
5.66B
40 days until earnings call
Intraday BUY SELL Signals
DNTH
Price
$47.80
Change
-$0.33 (-0.69%)
Updated
Feb 5, 02:43 PM (EDT)
Capitalization
2.08B
Intraday BUY SELL Signals
Interact to see
Advertisement

COGT vs DNTH

Header iconCOGT vs DNTH Comparison
Open Charts COGT vs DNTHBanner chart's image
Cogent Biosciences
Price$36.09
Change-$0.75 (-2.04%)
Volume$2.68K
Capitalization5.66B
Dianthus Therapeutics
Price$47.80
Change-$0.33 (-0.69%)
Volume$200
Capitalization2.08B
COGT vs DNTH Comparison Chart in %
COGT
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
COGT vs. DNTH commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Hold and DNTH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (COGT: $36.85 vs. DNTH: $48.13)
Brand notoriety: COGT and DNTH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 59% vs. DNTH: 128%
Market capitalization -- COGT: $5.66B vs. DNTH: $2.08B
COGT [@Biotechnology] is valued at $5.66B. DNTH’s [@Biotechnology] market capitalization is $2.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 1 FA rating(s) are green whileDNTH’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 1 green, 4 red.
  • DNTH’s FA Score: 1 green, 4 red.
According to our system of comparison, DNTH is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 3 TA indicator(s) are bullish while DNTH’s TA Score has 6 bullish TA indicator(s).

  • COGT’s TA Score: 3 bullish, 6 bearish.
  • DNTH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, DNTH is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а -3.94% price change this week, while DNTH (@Biotechnology) price change was -4.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.81%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +30.06%.

Reported Earning Dates

COGT is expected to report earnings on Mar 17, 2026.

Industries' Descriptions

@Biotechnology (-5.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($5.66B) has a higher market cap than DNTH($2.08B). DNTH YTD gains are higher at: 16.792 vs. COGT (3.744). DNTH has higher annual earnings (EBITDA): -139.9M vs. COGT (-308.13M). DNTH (403M) and COGT (391M) have equal amount of cash in the bank . DNTH has less debt than COGT: DNTH (1.29M) vs COGT (60.6M). DNTH has higher revenues than COGT: DNTH (3.08M) vs COGT (0).
COGTDNTHCOGT / DNTH
Capitalization5.66B2.08B272%
EBITDA-308.13M-139.9M220%
Gain YTD3.74416.79222%
P/E RatioN/A3.24-
Revenue03.08M-
Total Cash391M403M97%
Total Debt60.6M1.29M4,716%
FUNDAMENTALS RATINGS
COGT vs DNTH: Fundamental Ratings
COGT
DNTH
OUTLOOK RATING
1..100
7113
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
2619
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
3435
P/E GROWTH RATING
1..100
10066
SEASONALITY SCORE
1..100
5010

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DNTH's Valuation (69) in the null industry is in the same range as COGT (81) in the Miscellaneous industry. This means that DNTH’s stock grew similarly to COGT’s over the last 12 months.

DNTH's Profit vs Risk Rating (19) in the null industry is in the same range as COGT (26) in the Miscellaneous industry. This means that DNTH’s stock grew similarly to COGT’s over the last 12 months.

DNTH's SMR Rating (96) in the null industry is in the same range as COGT (99) in the Miscellaneous industry. This means that DNTH’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (34) in the Miscellaneous industry is in the same range as DNTH (35) in the null industry. This means that COGT’s stock grew similarly to DNTH’s over the last 12 months.

DNTH's P/E Growth Rating (66) in the null industry is somewhat better than the same rating for COGT (100) in the Miscellaneous industry. This means that DNTH’s stock grew somewhat faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTDNTH
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signal:
Gain/Loss:
DNTH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMFJX21.680.14
+0.65%
Principal MidCap S&P 400 Index J
HEOFX19.17-0.07
-0.36%
Hartford Climate Opportunities F
FUEPX63.54-0.37
-0.58%
American Funds EUPAC 529-F-2
IHOAX22.74-0.18
-0.79%
Hartford International Opportunities A
ADSIX21.85-0.31
-1.40%
American Century Disciplined Growth Inv

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been closely correlated with ERAS. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if COGT jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-1.15%
ERAS - COGT
79%
Closely correlated
+6.19%
ACET - COGT
79%
Closely correlated
-3.51%
INBX - COGT
78%
Closely correlated
-2.96%
ATOS - COGT
78%
Closely correlated
-4.34%
VTYX - COGT
76%
Closely correlated
-0.29%
More

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with VRDN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-8.25%
VRDN - DNTH
59%
Loosely correlated
-4.80%
SYRE - DNTH
59%
Loosely correlated
-3.66%
COGT - DNTH
57%
Loosely correlated
-1.15%
ATOS - DNTH
56%
Loosely correlated
-4.34%
SVRA - DNTH
53%
Loosely correlated
-5.30%
More